Literature DB >> 29723582

Mesenteric organ lymphatics and inflammatory bowel disease.

Yuanyuan Ge1, Yi Li2, Jianfeng Gong1, Weiming Zhu1.   

Abstract

Inflammatory bowel disease (IBD) is a complex gastrointestinal disorder and its etiology is unclear yet. Current theory in IBD is focused on genetics, immunity and intestinal microbes. Emerging clinical evidence and experimental results suggest that morphologic abnormalities and dysfunction of mesenteric lymphatics may have potential roles in the pathogenesis and disease course of IBD. In this review, we summarize the findings of specific investigations of the lymphatics and explore its role in IBD.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; Lymphatics; Ulcerative colitis

Mesh:

Year:  2018        PMID: 29723582     DOI: 10.1016/j.aanat.2018.03.006

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  4 in total

1.  Lipopolysaccharides modulate intestinal epithelial permeability and inflammation in a species-specific manner.

Authors:  Matthew Stephens; Pierre-Yves von der Weid
Journal:  Gut Microbes       Date:  2019-06-16

2.  Role of Extended Mesenteric Excision in Postoperative Recurrence of Crohn's Colitis: A Single-Center Study.

Authors:  Yipeng Zhu; Wenwei Qian; Liangyu Huang; Yihan Xu; Zhen Guo; Lei Cao; Jianfeng Gong; J Calvin Coffey; Bo Shen; Yi Li; Weiming Zhu
Journal:  Clin Transl Gastroenterol       Date:  2021-10-01       Impact factor: 4.488

3.  A Neglected Issue in Ulcerative Colitis: Mesenteric Lymph Nodes.

Authors:  Abdurrahman Sahin; Hakan Artas; Yesim Eroglu; Nurettin Tunc; Gulcan Oguz; Ulvi Demirel; Orhan Kursat Poyrazoglu; Mehmet Yalniz; Ibrahim Halil Bahcecioglu
Journal:  J Clin Med       Date:  2018-06-08       Impact factor: 4.241

4.  Mesenteric excision surgery or conservative limited resection in Crohn's disease: study protocol for an international, multicenter, randomized controlled trial.

Authors:  Yi Li; Helen Mohan; Nan Lan; Xiaojian Wu; Wei Zhou; Jianfeng Gong; Bo Shen; Luca Stocchi; J Calvin Coffey; Weiming Zhu
Journal:  Trials       Date:  2020-02-21       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.